New Reversible Hydrogel Contraceptive for Men Developed at Stellenbosch University

A groundbreaking study conducted at Stellenbosch University (SU) has revealed a promising new contraceptive method for men—a safer, more effective, and fully reversible option that could soon become available for widespread use. Kyla Raoult, who completed her master’s degree in Polymer Science at SU’s December graduation, has developed an innovative on-demand reversible hydrogel designed to serve as a non-hormonal birth control option for men. This development marks a major breakthrough in the field of male contraception.

Raoult’s hydrogel is a jelly-like material made from polymers that absorb water, causing it to swell and form a three-dimensional network with tiny pores. The hydrogel is designed to be injected into the vas deferens—the tube that carries sperm from the testicles to the urethra. Once injected, the hydrogel reacts to watery bodily fluids by swelling up and creating a semi-permeable barrier. The pores of the hydrogel allow seminal fluid to pass through but block the sperm, which are too large to fit through the pores. This barrier effectively prevents sperm from reaching the egg, and the blocked sperm is naturally reabsorbed by the body, much like the process that occurs after a vasectomy.

This method offers a huge advantage over traditional contraceptive methods, as it is both non-hormonal and reversible. The gel can be injected in a doctor’s office, forming the barrier in under a minute. Raoult explains that the hydrogel remains in place until the patient decides to restore fertility. To reverse the process, a solution is injected into the gel, breaking the chemical bonds that hold it together. This causes the gel to dissolve into a watery substance that can be flushed out, allowing the vas deferens to return to its natural state, thereby restoring fertility.

Although the technology is still in its developmental stage and requires further testing, Raoult’s innovation has the potential to address a significant gap in male contraceptive options. Currently, men have limited choices when it comes to contraception, with options primarily consisting of condoms, vasectomies, and some hormone-based methods. Condoms, while effective, are often used incorrectly and can decrease sexual stimulation. Vasectomies, on the other hand, are a permanent solution with a complicated and sometimes uncertain reversal process. Hormonal contraceptives for men are still being tested and have not yet been proven to be both safe and effective. Raoult’s hydrogel offers a much-needed alternative: a safe, reversible, non-hormonal method that could provide men with greater control over their reproductive health.

Raoult was inspired to explore this specific approach to contraception because most contraceptives are designed for women. She emphasized the growing need for a male contraceptive option that does not carry the side effects typically associated with hormonal treatments. “There is a clear need for a reversible, non-hormonal male contraceptive,” Raoult said. “Our technology could provide men with a one-time, easy-to-reverse option, helping them contribute to the prevention of unwanted pregnancies while promoting gender equality in contraception.”

Raoult’s work builds on previous research conducted at Stellenbosch University by her supervisor, Professor Bert Klumperman, from the Department of Chemistry & Polymer Science. The project is an extension of ongoing research into hydrogels for male contraception. One well-known hydrogel contraceptive called RISUG (Reversible Inhibition of Sperm Under Guidance) was developed in India about a decade ago and was based on a similar polymer. Raoult’s approach aims to improve the reversibility of this technology, making it more efficient and user-friendly for men.

Raoult’s breakthrough has generated significant interest among researchers, medical professionals, and the general public. Male contraception has long been an underdeveloped area, with much of the focus on female contraceptives. However, as societal norms evolve, there is an increasing demand for shared responsibility between men and women when it comes to contraception. By offering a non-hormonal, reversible option, Raoult’s hydrogel has the potential to provide men with more control over their reproductive health while contributing to gender equality in family planning.

Although the project is still in its early stages, Raoult has already begun working with NEXT Life Sciences, a biotechnology company based in the United States that is focused on advancing hydrogels for male contraception. The development of this hydrogel could revolutionize the way men approach contraception and fertility planning, offering them a simple, non-invasive, and easily reversible option.

However, Raoult is quick to point out that the hydrogel still needs further laboratory studies before it can be tested in clinical trials. While the technology shows great promise, the actual duration and effectiveness of the hydrogel still need to be confirmed through rigorous testing. As such, it is not yet possible to estimate when the hydrogel will be available on the market. Nonetheless, this development represents a significant step toward improving male contraception options and empowering men to take an active role in family planning.

The hydrogel could help address not only the contraceptive needs of men but also contribute to the broader conversation about reproductive rights and responsibilities. As the technology advances, it could help create a more balanced approach to contraception, where both partners share responsibility for preventing unintended pregnancies.

Follow Joburg ETC on Facebook, Twitter , TikTok and Instagram

For more News in Johannesburg, visit joburgetc.com